Lincoln Pharmaceuticals

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue170.59181.47183.08201.54200.88
Expenses141.78146.75166.38153.99171.86
EBITDA32.6638.7420.6651.6933.22
EBIT29.0435.0216.9747.8129.34
Profit Before Tax28.8134.7216.7047.5529.02
Net Profit19.9828.6011.6336.2320.43
Financial Ratios
Operating Profit Margin19.99%23.29%11.03%29.16%17.36%
Net Profit Margin12.23%17.20%6.21%20.44%10.68%
Earning Per Share (Diluted)9.9814.285.8118.0910.20
Dividends Per Share0.000.000.000.000.00